Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Quarterly Report on Form 10-Q contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. The words “believe,” “may,” “will,” “potentially,” “estimate,”
“continue,” “anticipate,” “intend,” “could,” “would,” “project,”
“plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to
identify forward-looking statements.These forward-looking statements speak only as of the date of this Form 10-Q and are subject to uncertainties,
assumptions and business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking
statements as a result of the factors set forth below in Part II, Item 1A, “Risk Factors,” and in our other reports filed
with the Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. Although
we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results,
levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. We
undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Form 10-Q to conform these
statements to actual results or to changes in our expectations, except as required by law.
The following discussion should be read in conjunction
with our unaudited condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form
10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially
different from what we expect.
Overview
Interlink Electronics, Inc. (“we”, “us”, “our”,
“Interlink” or the “Company”) designs, develops, manufactures and sells a range of force-sensing technologies
that incorporate our proprietary materials technology, firmware and software into a portfolio of standard products and custom solutions.
These include sensor components, subassemblies, modules and products that support effective, efficient cursor control and novel three-dimensional
user inputs. Our Human Machine Interface (“HMI”) technology platforms are deployed in a wide range of markets including consumer
electronics, automotive, industrial, and medical. The application of our HMI technology platforms includes vehicle entry, vehicle multi-media
control interface, rugged touch controls, presence detection, collision detection, speed and torque controls, biological monitoring and
others.
Interlink has been a leader in the printed electronics industry for
over 30 years with the commercialization of our patented Force-Sensing Resistor (“FSR®”) technology that has enabled rugged
and reliable HMI solutions. Our solutions have focused on handheld user input, menu navigation, cursor control, and other intuitive interface
technologies for the world’s top electronics manufacturers.
We invented FSR® technology and pioneered commercialization of
printed electronics manufacturing, paving the way for industry-wide adoption of force sensing technology. Our extensive knowledge and
experience with this technology, along with the firmware we incorporate in our HMI solutions, differentiates us from other providers of
HMI solutions. We, along with our customers, incorporate our FSR and force sensing sensors and modules into end user products. Our sensors
and modules are used in electronics devices and systems where user input must be converted into useful output data. Our force sensing
technology solution platforms enabled industry-first implementations in gaming, smartphone, rugged notebook, automotive cockpit and automotive
entry applications. Consumer and end-user demand for enhanced user experience is driving the need for innovative multi-modal HMI technologies
and applications. Force sensing input provides a critical novel modality that drives a paradigm shift in HMI.
Market requirements for innovative solutions that enable smaller, thinner
devices, lower power consumption, highly refined designs, better navigation and more intuitive usability in all environments, are also
driving increased demand for our products. Industry is moving towards the use of multi-modal HMI in the home, industrial, medical and
automotive spaces. Interlink delivers cutting edge, high performance HMI solutions for customers who wish to replace outdated switches
and knobs in these environments.
18
Significant market opportunities are rapidly emerging for us to improve
upon the functionality of standard capacitive sensors which are widely available and competitively priced. Inadvertent activation, where
users unintentionally activate a control, is a common problem with capacitive technology. In contrast, force sensing solutions require
a deliberate application of force to operate. We have had recent success in using our force sensing solutions in combination with capacitive
technologies to minimize the latter’s performance issues, enabling force sensing solutions to complement competitive technologies
and provide hybrid solutions and open up new opportunities for growth. We continue to simultaneously expand our standard product portfolio
and develop new technology platforms to grow existing markets and capture emerging markets. This portfolio expansion will incorporate
other complimentary sensing technologies. This broader portfolio of technologies will allow us to use our expertise in integrating multiple
sensing technologies for applications in the rapidly growing Internet-of-Things (“IoT”).
Interlink serves our world-wide customer base from our corporate headquarters
in Irvine, California (Orange County area) and from our facility in Camarillo, California (Ventura County). We plan to establish a Global
Product Development and Materials Science Center in our existing Camarillo footprint, which we expect to be operational in May 2021. This
facility will have a state-of-the-art printed electronics development laboratory as well as materials science lab. Our engineering team
will be based in this center where we will work with our U.S. and global customers on developing, engineering, prototyping and implementing
our advanced HMI solutions. We also maintain a small embedded software and IoT application development center in Singapore. We manufacture
all our products in our printed electronics manufacturing facility in Shenzhen, China, which has been in operation since 2006. In addition,
we maintain a global distribution and logistics center in Hong Kong, a technical sales office in Japan, and several manufacturer representatives
and distributors in strategic locations in our key markets, all of which allows us to support our global customer base. We sell our products
in a wide range of markets, including consumer electronics, automotive, industrial and medical. Our customers are some of the world’s
largest companies and most recognizable brands.
Critical Accounting Policies and Estimates
We prepare our consolidated financial statements in accordance with
generally accepted accounting principles in the United States (“GAAP”). The preparation of consolidated financial statements
requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and
related disclosures. We evaluate our estimates and assumptions on an ongoing basis. We base our estimates on historical experience and
on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from
the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial
statements presentation, financial condition, results of operations, and cash flows will be affected.
A description of our critical accounting policies that represent the
more significant judgments and estimates used in the preparation of our financial statements was provided in the Management’s Discussion
and Analysis of Financial Condition and Results of Operations section in our Annual Report on Form 10-K filed with the Securities
and Exchange Commission on March 17, 2021. There have been no changes to our critical accounting policies and estimates described
in the Form 10-K that have had a material impact on our condensed consolidated financial statements and related notes.
Recently Issued and Adopted Accounting Pronouncements
Recent accounting pronouncements are detailed in Note 1 to our condensed
consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
19
Results of Operations
The following table sets forth certain unaudited
condensed consolidated statements of income data for the periods indicated. The percentages in the table are based on net revenues.
Three months ended March 31,
2021
2020
$
%
$
%
(in thousands, except percentages)
Revenue, net
$ 1,568
100.0 %
$ 1,691
100.0 %
Cost of revenue
694
44.3 %
732
43.3 %
Gross profit
874
55.7 %
959
56.7 %
Operating expenses:
Engineering, research and development
217
13.8 %
285
16.9 %
Selling, general and administrative
717
45.7 %
746
44.1 %
Total operating expenses
934
59.6 %
1,031
61.0 %
Income (loss) from operations
(60 )
(3.8 )%
(72 )
(4.3 )%
Other income (expense):
Other income (expense), net
10
0.6 %
6
0.4 %
Income (loss) before income taxes
(50 )
(3.2 )%
(66 )
(3.9 )%
Income tax expense (benefit)
(7 )
(0.4 )%
(48 )
(2.8 )%
Net income (loss)
$ (43 )
(2.7 )%
$ (18 )
(1.1 )%
Comparison of Three Months Ended March 31, 2021 and 2020
Revenue, net by the markets we serve is as follows:
Three months ended March 31,
2021
2020
Amount
% of
Net Revenue
Amount
% of
Net Revenue
$ Change
% Change
(in thousands, except percentages)
Industrial
$ 538
34.3 %
$ 392
23.2 %
$ 146
37.2 %
Medical
43
2.7 %
404
23.9 %
(361 )
(89.4 )%
Consumer
449
28.6 %
187
11.1 %
262
140.1 %
Standard
538
34.3 %
708
41.8 %
(170 )
(24.0 )%
Revenue, net
$ 1,568
100.0 %
$ 1,691
100.0 %
$ (123 )
(7.3 )%
We sell our custom products into the industrial, medical and consumer
markets. We previously sold custom products in the automotive market and continue to pursue opportunities in that sector. We sell our
standard products through various distribution networks. The ultimate customer for standard products may come from different markets which
are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often
have much longer product life-cycles. Industrial and medical products generally have longer design and life-cycles than consumer products.
We currently have products with life-cycles that have exceeded twenty years and are ongoing.
Revenues were up in the three months ended March 31, 2021
compared to the three months ended March 31, 2020 in the industrial and consumer markets, and were down in the medical markets
and for our standard products. The increase in revenue from our industrial market customers is due to increased purchasing volume by
these customers for use in their ongoing product lines resulting from changes in demand by their customers. The increase in revenue
from our consumer market customers is due to an increase in purchase levels on corresponding products and programs. The decrease in
revenue from our medical market customers is primarily due to significant reduction of shipments to our largest medical customer,
which is subject to delays in installing devices that use our products in hospitals due to COVID-19 restrictions. The decrease in
revenue on our standard products is due to cyclical purchasing pattern of some of our larger customers who took delivery of bulk
quantities during 2020. In the normal cycle, some of our larger customers purchase in bulk quantities and absorption of these
products can straddle several financial reporting periods. In all markets, the timing of orders from our customers is not always
predictable and can be concentrated in varying periods during the year to coincide with their project and building plans.
20
Three months ended March 31,
2021
2020
Amount
% of
Net Revenue
Amount
% of
Net Revenue
$ Change
% Change
(in thousands, except percentages)
Gross profit
$ 874
55.7 %
$ 959
56.7 %
$ (85 )
(8.9 )%
Our gross profit and gross margin percentage are impacted by various
factors including product mix, customer mix, volume, material costs, manufacturing efficiencies, facilities costs, compensation costs
and provisions for excess and obsolete inventories. The decrease in gross profit for the three months ended March 31, 2021 as compared
with the prior year was due to the decrease in revenues, while gross margin percentage was substantially unchanged.
Three months ended March 31,
2021
2020
Amount
% of
Net Revenue
Amount
% of
Net Revenue
$ Change
% Change
(in thousands, except percentages)
Engineering, research and development
$ 217
13.8 %
$ 285
16.9 %
$ (68 )
(23.9 )%
Engineering and R&D expenses consist primarily of compensation
expenses for employees engaged in research, design and development activities. Our R&D team focuses both on internal design development,
as well as design development aimed at addressing customer design challenges, in order to develop our HMI solutions.
Our engineering and R&D costs were down for the three months ended
March 31, 2021 when compared with the prior year because we reduced costs and headcount at our Singapore R&D center during 2020
as part of the transfer of the lab to Camarillo, California.
Three months ended March31,
2021
2020
Amount
% of
Net Revenue
Amount
% of
Net Revenue
Change
% Change
(in thousands, except percentages)
Selling, general and administrative
$ 717
45.7 %
$ 746
44.1 %
$ (29 )
(3.9 )%
Selling, general and administrative expenses consist primarily of compensation
expenses, legal and other professional fees, facilities expenses and communication expenses. Selling, general and administrative expenses
decreased during the three months ended March 31, 2021 as compared with the prior year due to recording forgiveness of the $186 thousand
PPP loan, offset by increases in sales, marketing, finance and administrative personnel, and an increase in legal costs and filing fees
associated with relisting with Nasdaq during the quarter.
Three months ended March 31,
2021
2020
Amount
% of
Pre-tax Income
Amount
% of
Pre-tax Income
Change
% Change
(in thousands, except percentages)
Income tax expense (benefit)
$ (7 )
14.0 %
$ (48 )
(72.7 )%
$ 41
nm %
Income tax expense (benefit) reflects statutory tax rates in the jurisdictions
that we operate adjusted for normal book/tax differences. The tax benefit for the three month periods ended March 31, 2021 and 2020
was a result of operating losses for the quarters.
21
Our effective tax rate is directly affected by the relative proportions
of income before taxes in the jurisdictions in which we operate. Based on the expected mix of domestic and foreign earnings, we anticipate
our effective tax rate to remain lower than the U.S. statutory rate primarily due to a significant portion of our earnings originating
in lower rate foreign jurisdictions. Discrete tax events may cause our effective rate to fluctuate on a quarterly basis. Certain events,
including, for example, acquisitions and other business changes, which are difficult to predict, may also cause our effective tax rate
to fluctuate. We are subject to changing tax laws, regulations, and interpretations in multiple jurisdictions. Continued corporate tax
reform continues to be a priority in the U.S. and other jurisdictions. Additional changes to the tax system in the U.S. could have significant
effects, positive and negative, on our effective tax rate, and on our deferred tax assets and liabilities.
Liquidity and Capital Resources
Cash requirements for working capital and capital expenditures have
been funded from cash balances on hand and cash generated from operations. As of March 31, 2021, we had cash and cash equivalents
of $6.1 million, working capital of $7.5 million and no indebtedness. Cash and cash equivalents consist of cash and money market
funds. We did not have any short-term or long-term investments as of March 31, 2021. Of the $6.1 million of cash balances on
hand, $1.7 million was held by foreign subsidiaries. If these funds are needed for our operations in the U.S., we have several methods
to repatriate without significant tax effects, including repayment of intercompany loans or distributions of previously taxed income.
Other distributions may require us to incur U.S. or foreign taxes to repatriate these funds. However, our intent is to permanently reinvest
these funds outside the U.S. and our current plans do not demonstrate a need to repatriate cash to fund our U.S. operations.
During the second quarter of 2020, the Company received a loan from
Silicon Valley Bank in the aggregate principal amount of $186 thousand pursuant to the Paycheck Protection Program (the “PPP”)
under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The loan was evidenced by a promissory note,
dated April 21, 2020, issued by us to the lender, which was scheduled to mature on April 20, 2022, and bore interest at a rate of
1.00% per annum. Proceeds from the loan were used to fund designated expenses, including certain payroll costs, group health care benefits
and other permitted expenses, in accordance with the PPP. Under the terms of the PPP, up to the entire amount of principal and accrued
interest was eligible to be forgiven to the extent loan proceeds are used for qualifying expenses as described in the CARES Act and applicable
implementing guidance issued by the U.S. Small Business Administration under the PPP. The full amount of the loan principal and interest
was forgiven in February 2021.
We believe that our existing cash and cash equivalents balance will
be sufficient to maintain our current operations considering our current financial condition, obligations, and other expected cash flows.
If our circumstances change, however, we may require additional cash. If we require additional cash, we may attempt to raise additional
capital through equity, equity-linked or debt financing arrangements. If we raise additional funds by issuing equity or equity-linked
securities, the ownership of our existing stockholders will be diluted. If we raise additional financing by the incurrence of indebtedness,
we could be subject to fixed payment obligations and could also be subject to restrictive covenants, such as limitations on our ability
to incur additional debt, and other operating restrictions that could adversely impact our ability to conduct our business. If we are
unable to raise additional needed funds, we may also take measures to reduce expenses to offset any shortfall.
22
Cash Flow Analysis
Our cash flows from operating, investing and financing
activities are summarized as follows:
Three Months Ended
March 31,
2021
2020
(in thousands)
Net cash provided by (used in) operating activities
$ (1 )
$ 263
Net cash used in investing activities
(12 )
(34 )
Net cash provided by financing activities
—
—
Net Cash Provided by Operating Activities
For the three months ended March 31, 2021, the $1 thousand
of cash used in operating activities was attributable to net loss of $43 thousand, adjusted for non-cash charges of $136 thousand,
non-cash gain on forgiveness of PPP loan of $186 thousand, and cash provided by changes in operating assets and liabilities of $92 thousand.
For the three months ended March 31, 2020, the $263 thousand
of cash provided by operating activities was attributable to net loss of $18 thousand, adjusted for non-cash charges of $142 thousand,
and cash provided by changes in operating assets and liabilities of $139 thousand.
Accounts receivable decreased from $1,113 thousand at December
31, 2020 to $970 thousand at March 31, 2021 due to lower shipments during the first quarter of 2021 compared to the fourth quarter
of 2020. Many of our customers pay promptly and accounts receivable is generally related to the most recent shipments. Inventories increased
from $866 thousand at December 31, 2020 to $881 thousand at March 31, 2021. Inventory balances fluctuate depending on the
timing of materials purchases and product shipments. Prepaid expenses and other current assets decreased from $392 thousand at December
31, 2020 to $337 thousand at March 31, 2021, and accounts payable and accrued liabilities increased from $578 thousand
at December 31, 2020 to $581 thousand at March 31, 2021, primarily due to the timing of payment for purchases of materials and
other services provided.
Net Cash Used in Investing Activities
Net cash used in investing activities of $12 thousand for the
three months ended March 31, 2021 consisted purchases of property, plant, and equipment. Net cash used in investing activities of
$34 thousand for the three months ended March 31, 2020 consisted of legal costs related to securing patents on new products
and processes developed thereunder.
Net Cash Provided by Financing Activities
There was no cash provided by or used in financing activities during
the three months ended March 31, 2021 and 2020.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not Applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.